Use access key #2 to skip to page content.
$0.97 -0.13 (-11.82%)
10/10/2008 2:23 PM

GPC Biotech AG (ADR) (GPCB)

CAPS Rating:
*

The Company is publicly traded biopharmaceutical company focused on discovering, developing and commercializing new anticancer drugs.

View All Commentary (GPCB)

Recs

0

Avatar JonAtkins57 (< 20) Submitted: 6/30/08 1:50 PM : Underperform Start Price: $3.78 GPCB Score: 42.46

Market Cap > 100M and < 1B
Gross Margin % < -10
Net Profit Margin % < -10
EPS < -1

Report this Post Replies: 0 | Reply

Featured Broker Partners